Wordt geladen...
Odds of death after glioblastoma diagnosis in the United States by chemotherapeutic era
Bevacizumab (BZM) and temozolomide (TMZ) have been shown to be beneficial in the treatment of patients with glioblastoma. We sought evidence for the benefit of BZM in the general patient population at large. The Surveillance, Epidemiology, and End Results SEER database was queried for patients diagn...
Bewaard in:
| Hoofdauteurs: | , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
BlackWell Publishing Ltd
2014
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4101757/ https://ncbi.nlm.nih.gov/pubmed/24610705 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.213 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|